Improving the efficacy and delivery of therapeutics for cardiovascular disease
Abstract
Cardiovascular disease is the leading cause of death globally. lschemic heart disease, including myocardial infarction accounts for half of cardiovascular disease related deaths. Removal of the coronary obstruction causing myocardial infarction is associated with an increase in subsequent damage to the heart, a paradox known as ischemia reperfusion injury. This thesis investigates the use of novel peptides and delivery mechanisms to improve therapeutics for cardiovascular disease. Optimised nanotechnology represents a platform to deliver peptides as a therapeutic approach for the prevention of ischemia reperfusion injury. If clinically translated, this treatment can significantly reduce cardiovascular disease associated morbidity and morality.
Related Papers
- → Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury (Review)(2014)131 cited
- → Seek and Hide Phosphatidylserine: A New Approach to Prevent Hepatic Ischemia/Reperfusion Injury(2007)6 cited
- → Biotechnology-Derived Cardiovascular Therapeutics and Toxicity(2003)2 cited
- NADPH Oxidase - a Therapeutic Target to Restore Endothelial Function in Insulin Resistance(2011)
- → Abstract P106: Development Of An Oral Drug Delivery System For The Cardio-protective Neuropeptide Alpha-calcitonin Gene Related Peptide(2021)